JPRN-jRCT2080222900未知3 期
A Long-term Phase III Study of TK-041 in Patients with Perennial Allergic Rhinitis
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 12age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Diagnosed with perennial allergic rhinitis and the symptoms will be expected to continue for more than 12 weeks after the start of treatment
排除标准
- •Nose diseases (nasal polypus, nasal septum curvature symptom, hypertrophic rhinitis, etc.) or infectious diseases (upper respiratory tract inflammation, sinusitis, infectious rhinitis, infectious ophthalmopathy, etc.) that may interfere with the evaluation
- •Hypersensitivity to antihistamine drugs or study drug
研究者
相似试验
未知
3 期
A Phase III Long-Term Study of TK-041 in Patients with Pruritus Accompanied by Skin DiseasesJPRN-jRCT2080222735TEIKOKU SEIYAKU CO., LTD.180
已完成
3 期
ong-term safety and efficacy of TK-023 in Patients with Severe Dementia of the Alzheimer's TypeDementia of the Alzheimer's typeJPRN-jRCT2080224612TEIKOKU SEIYAKU Co., LTD.70
未知
3 期
Phase III long-term study of TAK-536CCB in patients with grade I or II essential hypertensioHypertensionJPRN-jRCT2080221586TAKEDA PHARMACEUTICAL COMPANY LTD.
已完成
3 期
A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) ParticipantsPrimary Immunodeficiency Diseases (PID)NCT05513586Takeda15
未知
3 期
MK-0431/ONO-5435 Phase III Clinical Study - Long-term Treatment Study for Patients with Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-jRCT2080220289ONO PHARMACEUTICAL CO.,LTD.